chr5-177210239-G-T

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1

The NM_022455.5(NSD1):​c.1840G>T​(p.Val614Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.138 in 1,597,604 control chromosomes in the GnomAD database, including 19,804 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.14 ( 1923 hom., cov: 31)
Exomes 𝑓: 0.14 ( 17881 hom. )

Consequence

NSD1
NM_022455.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.285
Variant links:
Genes affected
NSD1 (HGNC:14234): (nuclear receptor binding SET domain protein 1) This gene encodes a protein containing a SET domain, 2 LXXLL motifs, 3 nuclear translocation signals (NLSs), 4 plant homeodomain (PHD) finger regions, and a proline-rich region. The encoded protein enhances androgen receptor (AR) transactivation, and this enhancement can be increased further in the presence of other androgen receptor associated coregulators. This protein may act as a nucleus-localized, basic transcriptional factor and also as a bifunctional transcriptional regulator. Mutations of this gene have been associated with Sotos syndrome and Weaver syndrome. One version of childhood acute myeloid leukemia is the result of a cryptic translocation with the breakpoints occurring within nuclear receptor-binding Su-var, enhancer of zeste, and trithorax domain protein 1 on chromosome 5 and nucleoporin, 98-kd on chromosome 11. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Sep 2018]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), NSD1. . Gene score misZ 3.4113 (greater than the threshold 3.09). Trascript score misZ 5.7368 (greater than threshold 3.09). GenCC has associacion of gene with Beckwith-Wiedemann syndrome, Weaver syndrome, Sotos syndrome 1, Sotos syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=9.2281436E-5).
BP6
Variant 5-177210239-G-T is Benign according to our data. Variant chr5-177210239-G-T is described in ClinVar as [Benign]. Clinvar id is 96042.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-177210239-G-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.493 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
NSD1NM_022455.5 linkuse as main transcriptc.1840G>T p.Val614Leu missense_variant 5/23 ENST00000439151.7 NP_071900.2 Q96L73-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
NSD1ENST00000439151.7 linkuse as main transcriptc.1840G>T p.Val614Leu missense_variant 5/231 NM_022455.5 ENSP00000395929.2 Q96L73-1

Frequencies

GnomAD3 genomes
AF:
0.135
AC:
20563
AN:
151934
Hom.:
1926
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0764
Gnomad AMI
AF:
0.0570
Gnomad AMR
AF:
0.170
Gnomad ASJ
AF:
0.112
Gnomad EAS
AF:
0.510
Gnomad SAS
AF:
0.248
Gnomad FIN
AF:
0.188
Gnomad MID
AF:
0.0854
Gnomad NFE
AF:
0.122
Gnomad OTH
AF:
0.122
GnomAD3 exomes
AF:
0.179
AC:
42796
AN:
239304
Hom.:
5414
AF XY:
0.176
AC XY:
22851
AN XY:
129698
show subpopulations
Gnomad AFR exome
AF:
0.0748
Gnomad AMR exome
AF:
0.235
Gnomad ASJ exome
AF:
0.112
Gnomad EAS exome
AF:
0.517
Gnomad SAS exome
AF:
0.215
Gnomad FIN exome
AF:
0.184
Gnomad NFE exome
AF:
0.118
Gnomad OTH exome
AF:
0.154
GnomAD4 exome
AF:
0.138
AC:
199439
AN:
1445552
Hom.:
17881
Cov.:
38
AF XY:
0.140
AC XY:
100517
AN XY:
717724
show subpopulations
Gnomad4 AFR exome
AF:
0.0681
Gnomad4 AMR exome
AF:
0.222
Gnomad4 ASJ exome
AF:
0.113
Gnomad4 EAS exome
AF:
0.504
Gnomad4 SAS exome
AF:
0.217
Gnomad4 FIN exome
AF:
0.185
Gnomad4 NFE exome
AF:
0.116
Gnomad4 OTH exome
AF:
0.149
GnomAD4 genome
AF:
0.135
AC:
20564
AN:
152052
Hom.:
1923
Cov.:
31
AF XY:
0.143
AC XY:
10662
AN XY:
74314
show subpopulations
Gnomad4 AFR
AF:
0.0762
Gnomad4 AMR
AF:
0.170
Gnomad4 ASJ
AF:
0.112
Gnomad4 EAS
AF:
0.510
Gnomad4 SAS
AF:
0.248
Gnomad4 FIN
AF:
0.188
Gnomad4 NFE
AF:
0.122
Gnomad4 OTH
AF:
0.123
Alfa
AF:
0.126
Hom.:
3798
Bravo
AF:
0.130
TwinsUK
AF:
0.107
AC:
398
ALSPAC
AF:
0.108
AC:
417
ESP6500AA
AF:
0.0704
AC:
310
ESP6500EA
AF:
0.114
AC:
982
ExAC
AF:
0.174
AC:
21135
Asia WGS
AF:
0.332
AC:
1151
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoFeb 08, 2013- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jun 10, 2013- -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Sotos syndrome Benign:2
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 15, 2021- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpNov 03, 2022- -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsMar 19, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.080
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
0.0070
DANN
Benign
0.53
DEOGEN2
Benign
0.060
.;T;.
Eigen
Benign
-1.7
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.060
N
LIST_S2
Benign
0.64
T;T;.
MetaRNN
Benign
0.000092
T;T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
0.26
.;N;.
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-0.47
N;N;N
REVEL
Benign
0.19
Sift
Benign
0.32
T;T;T
Sift4G
Benign
0.91
T;T;T
Polyphen
0.0020
B;B;B
Vest4
0.14
MutPred
0.14
.;Loss of MoRF binding (P = 0.0946);.;
MPC
0.054
ClinPred
0.0017
T
GERP RS
-1.3
Varity_R
0.024
gMVP
0.16

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3733875; hg19: chr5-176637240; COSMIC: COSV61771212; COSMIC: COSV61771212; API